296 related articles for article (PubMed ID: 32946609)
1. The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.
Trivioli G; Vaglio A
Clin Exp Immunol; 2020 Dec; 202(3):403-406. PubMed ID: 32946609
[TBL] [Abstract][Full Text] [Related]
2. Complement system activation in ANCA vasculitis: A translational success story?
Kallenberg CG; Heeringa P
Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Å; Skattum L
PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309
[TBL] [Abstract][Full Text] [Related]
4. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
5. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
[TBL] [Abstract][Full Text] [Related]
6. The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation.
Hao J; Huang YM; Zhao MH; Chen M
Arthritis Res Ther; 2014 Jul; 16(4):R142. PubMed ID: 25000985
[TBL] [Abstract][Full Text] [Related]
7. How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Roccatello D; Fenoglio R; Oddone V; Sciascia S
Kidney Blood Press Res; 2022; 47(8):506-513. PubMed ID: 35665698
[TBL] [Abstract][Full Text] [Related]
8. Complement in ANCA-associated vasculitis.
Charles Jennette J; Xiao H; Hu P
Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040
[TBL] [Abstract][Full Text] [Related]
9. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil extracellular traps can activate alternative complement pathways.
Wang H; Wang C; Zhao MH; Chen M
Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
[TBL] [Abstract][Full Text] [Related]
11. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.
Schreiber A; Xiao H; Jennette JC; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2009 Feb; 20(2):289-98. PubMed ID: 19073822
[TBL] [Abstract][Full Text] [Related]
12. C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
Yuan J; Gou SJ; Huang J; Hao J; Chen M; Zhao MH
Arthritis Res Ther; 2012 Jun; 14(3):R140. PubMed ID: 22691190
[TBL] [Abstract][Full Text] [Related]
13. Complement in ANCA-associated glomerulonephritis.
Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
[TBL] [Abstract][Full Text] [Related]
14. A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation.
Hao J; Wang C; Yuan J; Chen M; Zhao MH
PLoS One; 2013; 8(6):e66305. PubMed ID: 23785491
[TBL] [Abstract][Full Text] [Related]
15. The complement system in antineutrophil cytoplasmic antibody-associated vasculitis: pathogenic player and therapeutic target.
Mazzariol M; Manenti L; Vaglio A
Curr Opin Rheumatol; 2023 Jan; 35(1):31-36. PubMed ID: 36301247
[TBL] [Abstract][Full Text] [Related]
16. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
[TBL] [Abstract][Full Text] [Related]
17. Complement in ANCA-associated vasculitis: mechanisms and implications for management.
Chen M; Jayne DRW; Zhao MH
Nat Rev Nephrol; 2017 Jun; 13(6):359-367. PubMed ID: 28316335
[TBL] [Abstract][Full Text] [Related]
18. p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation.
Hao J; Meng LQ; Xu PC; Chen M; Zhao MH
PLoS One; 2012; 7(5):e38317. PubMed ID: 22675451
[TBL] [Abstract][Full Text] [Related]
19. Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside.
Brilland B; Garnier AS; Chevailler A; Jeannin P; Subra JF; Augusto JF
Autoimmun Rev; 2020 Jan; 19(1):102424. PubMed ID: 31734405
[TBL] [Abstract][Full Text] [Related]
20. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
